SCHEMBL5194709

SCHEMBL5194709

CCn1c(-c2ccc(C(F)(F)F)cc2C(F)(F)F)nc(-c2ccncc2)c1-c1ccc(Cl)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TEK Q02763 1/20 0.39
NR1H2 P55055 1/20 0.39
NR1H3 Q13133 1/20 0.39
MAPK13 O15264 2/20 0.37
MAPK12 P53778 2/20 0.37
MAPK11 Q15759 2/20 0.37
MAPK14 Q16539 2/20 0.37
OPRL1 P41146 1/20 0.36
KIF11 P52732 1/20 0.36
GCGR P47871 3/20 0.36
S1PR1 P21453 2/20 0.35
DPP4 P27487 1/20 0.35
FABP4 P15090 2/20 0.35
FABP5 Q01469 1/20 0.35
DHODH Q02127 1/20 0.34
DHFR P00374 1/20 0.34
CNR1 P21554 1/20 0.34
SRC P12931 1/20 0.34
BRAF P15056 1/20 0.34
KDR P35968 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5197144 0.78 TEK (0.41) TEKMAPK13MAPK12MAPK11MAPK14
SCHEMBL5200226 0.77 FABP4 (0.43) TEKMAPK13MAPK12MAPK11MAPK14
SCHEMBL5198855 0.77 TEK (0.44) TEKMAPK13MAPK12MAPK11MAPK14
SCHEMBL5197308 0.76 TEK (0.45) TEKMAPK13MAPK12MAPK11MAPK14
SCHEMBL5199376 0.76 CYP19A1 (0.45) NR1H2NR1H3MAPK13MAPK12MAPK11
SCHEMBL17955978 0.76 MALT1 (0.43) NR1H2NR1H3DHODH
SCHEMBL5198712 0.76 TEK (0.48) TEKNR1H3MAPK13MAPK12MAPK11
Methyl Alcohol SCHEMBL27727314 0.75 FABP4 (0.53) TEKNR1H3MAPK13MAPK12MAPK11
SCHEMBL5197690 0.75 MAPK14 (0.44) TEKNR1H3MAPK13MAPK12MAPK11
SCHEMBL5197084 0.75 TEK (0.46) TEKMAPK13MAPK12MAPK11MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1846389-A1 IMIDAZOLE DERIVATIVES F. Hoffmann-Roche AG (CH) 2007-10-24 EP claimed
WO-2006082002-A1 IMIDAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2006-08-10 WO claimed
US-20060173048-A1 Imidazole derivatives F. HOFFMAN-LA ROCHE AG (CH) 2006-08-03 US claimed
EP-1846389-A1 IMIDAZOLE DERIVATIVES F. Hoffmann-Roche AG (CH) 2007-10-24 EP disclosed
WO-2006082002-A1 IMIDAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2006-08-10 WO disclosed
US-20060173048-A1 Imidazole derivatives F. HOFFMAN-LA ROCHE AG (CH) 2006-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060173048-A1 Imidazole derivatives GRM2, GRM1, GRIN2C TEK 3703/4885NR1H2 262/4885NR1H3 372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.